The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

By Ciruelos Gil, Eva María | Pascual Martínez, Pascual | Arroyo Vozmediano, María Luisa | Blanco Guerrero, Marta | Manso Sánchez, Luis | Parrilla Rubio, Lucía | Muñoz, César | Vega Alonso, Estela | Calderón, Monica Jackelin | Sancho, Blanca | Cortés-Funes Castro, Hernán. The Breast : official journal of the European Society of Mastology, 2014 . 23(3):201-8. , Formato Vancouver: Ciruelos E, Pascual T, Arroyo Vozmediano ML, Blanco M, Manso L, Parrilla L et al. The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer. Breast. 2014 Jun;23(3):201-8.

Place Hold on The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

By Ciruelos Gil, Eva María | Cortés-Funes Castro, Hernán | Dorta Suárez, Myriam | Ghanem Cañete, Ismael | Manneh Kopp, Ray | Manso Sánchez, Luis | Mendiola Fernández, César | Sepúlveda Sánchez, Juan Manuel | Valdiviezo N, | Vega Alonso, Estela. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 . 15(6):467-71. , Formato Vancouver: Manso L, Valdiviezo N, Sepúlveda J, Ciruelos E, Mendiola C, Ghanem I, et al. Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients. Clin Transl Oncol. 2013 Jun;15(6):467-71.

Place Hold on Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

Search for 'an,phr: 432' with limit(s): 'au:Vega Alonso, Estela'

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.